Published in Kidney Int on September 01, 2004
Guidelines for the management of chronic kidney disease. CMAJ (2008) 2.54
Serious Non-AIDS events: Immunopathogenesis and interventional strategies. AIDS Res Ther (2013) 1.01
Efficacy and safety of lanthanum carbonate on chronic kidney disease-mineral and bone disorder in dialysis patients: a systematic review. BMC Nephrol (2013) 0.91
Safety and efficacy of nicotinamide in the management of hyperphosphatemia in patients on hemodialysis. Indian J Nephrol (2011) 0.87
Do aluminium-based phosphate binders continue to have a role in contemporary nephrology practice? BMC Nephrol (2011) 0.86
Combined alkaline phosphatase and phosphorus levels as a predictor of mortality in maintenance hemodialysis patients. Medicine (Baltimore) (2014) 0.85
Clinical and economic aspects of sevelamer therapy in end-stage renal disease patients. Int J Nephrol Renovasc Dis (2014) 0.81
Kidney disease outcomes quality initiative guidelines for bone and mineral metabolism: emerging questions. Semin Nephrol (2009) 0.79
Efficacy and safety of nicotinamide in the management of hyperphosphatemia in pediatric patients on regular hemodialysis. Pediatr Nephrol (2015) 0.78
Treatment options of secondary hyperparathyroidism (SHPT) in patients with chronic kidney disease stages 3 and 4: an historic review. Clin Cases Miner Bone Metab (2009) 0.78
Economic impact of sevelamer in patients with ESRD. Kidney Int (2005) 0.76
Sevelamer as a phosphate binder in adult hemodialysis patients: an evidence-based review of its therapeutic value. Core Evid (2005) 0.76
Phosphate binders in patients with chronic kidney disease. Aust Prescr (2017) 0.75
Opportunity and cost of sevelamer in dialysis patients. Kidney Int (2005) 0.75
Effect of low dose nicotinic acid on hyperphosphatemia in patients with end stage renal disease. Indian J Nephrol (2016) 0.75
Effects of Sevelamer Hydrochloride on Uremic Toxins Serum Indoxyl Sulfate and P-Cresyl Sulfate in Hemodialysis Patients. J Clin Med Res (2017) 0.75
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 41.47
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 26.95
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. Science (2010) 9.61
Relation between kidney function, proteinuria, and adverse outcomes. JAMA (2010) 8.26
Age and association of kidney measures with mortality and end-stage renal disease. JAMA (2012) 7.20
Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate. JAMA (2012) 6.26
The contribution of chronic kidney disease to the global burden of major noncommunicable diseases. Kidney Int (2011) 6.21
Effectiveness of quality improvement strategies on the management of diabetes: a systematic review and meta-analysis. Lancet (2012) 5.65
Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts. Kidney Int (2011) 5.47
Effect of frequent nocturnal hemodialysis vs conventional hemodialysis on left ventricular mass and quality of life: a randomized controlled trial. JAMA (2007) 5.31
The relationship between visit-to-visit variability in systolic blood pressure and all-cause mortality in the general population: findings from NHANES III, 1988 to 1994. Hypertension (2011) 5.14
Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis. Lancet (2012) 5.10
Validity of International Classification of Diseases, Ninth Revision, Clinical Modification Codes for Acute Renal Failure. J Am Soc Nephrol (2006) 4.95
Recommendations on screening for breast cancer in average-risk women aged 40-74 years. CMAJ (2011) 4.68
Systematic review and meta-analysis: renal safety of tenofovir disoproxil fumarate in HIV-infected patients. Clin Infect Dis (2010) 4.28
Health Effects of Overweight and Obesity in 195 Countries over 25 Years. N Engl J Med (2017) 3.90
When laboratories report estimated glomerular filtration rates in addition to serum creatinines, nephrology consults increase. Kidney Int (2009) 3.70
Benefits and harms of statin therapy for persons with chronic kidney disease: a systematic review and meta-analysis. Ann Intern Med (2012) 3.62
Renal insufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort study. Circulation (2004) 3.56
Recommendations on screening for type 2 diabetes in adults. CMAJ (2012) 3.51
Recommendations on screening for cervical cancer. CMAJ (2013) 3.32
Intensive and Standard Blood Pressure Targets in Patients With Type 2 Diabetes Mellitus: Systematic Review and Meta-analysis. Arch Intern Med (2012) 3.26
Early recognition and prevention of chronic kidney disease. Lancet (2010) 3.19
Association between glycemic control and adverse outcomes in people with diabetes mellitus and chronic kidney disease: a population-based cohort study. Arch Intern Med (2011) 3.13
Prognostic value of troponin T and I among asymptomatic patients with end-stage renal disease: a meta-analysis. Circulation (2005) 3.10
Change in the estimated glomerular filtration rate over time and risk of all-cause mortality. Kidney Int (2013) 3.05
A systematic review of the effect of nocturnal hemodialysis on blood pressure, left ventricular hypertrophy, anemia, mineral metabolism, and health-related quality of life. Kidney Int (2005) 3.03
Association between pulse pressure and mortality in patients undergoing maintenance hemodialysis. JAMA (2002) 2.98
Meta-analysis: erythropoiesis-stimulating agents in patients with chronic kidney disease. Ann Intern Med (2010) 2.97
Glomerular filtration rate, proteinuria, and the incidence and consequences of acute kidney injury: a cohort study. Lancet (2010) 2.95
Oral estrogen therapy in postmenopausal women is associated with loss of kidney function. Kidney Int (2008) 2.88
Hetastarch and bleeding complications after coronary artery surgery. Chest (2003) 2.87
Statins for improving renal outcomes: a meta-analysis. J Am Soc Nephrol (2006) 2.84
The comparative short-term effectiveness of iron dosing and formulations in US hemodialysis patients. Am J Med (2013) 2.77
Cystatin C as a risk factor for outcomes in chronic kidney disease. Ann Intern Med (2007) 2.71
Comparative mortality risk of anemia management practices in incident hemodialysis patients. JAMA (2010) 2.71
Estimating equations for glomerular filtration rate in the era of creatinine standardization: a systematic review. Ann Intern Med (2012) 2.69
Nephrology visits and health care resource use before and after reporting estimated glomerular filtration rate. JAMA (2010) 2.61
Improvements in long-term mortality after myocardial infarction and increased use of cardiovascular drugs after discharge: a 10-year trend analysis. J Am Coll Cardiol (2008) 2.58
Overview of the Alberta Kidney Disease Network. BMC Nephrol (2009) 2.58
Nocturnal hemodialysis does not improve overall measures of quality of life compared to conventional hemodialysis. Kidney Int (2008) 2.56
Guidelines for the management of chronic kidney disease. CMAJ (2008) 2.54
Prevention of dialysis catheter malfunction with recombinant tissue plasminogen activator. N Engl J Med (2011) 2.48
Rates of treated and untreated kidney failure in older vs younger adults. JAMA (2012) 2.43
Mycophenolate mofetil for induction therapy of lupus nephritis: a systematic review and meta-analysis. Clin J Am Soc Nephrol (2007) 2.38
Systematic review of the impact of N-acetylcysteine on contrast nephropathy. Kidney Int (2004) 2.37
The association among renal insufficiency, pharmacotherapy, and outcomes in 6,427 patients with heart failure and coronary artery disease. J Am Coll Cardiol (2004) 2.32
Weekend hospital admission, acute kidney injury, and mortality. J Am Soc Nephrol (2010) 2.30
Renal replacement therapy in patients with acute renal failure: a systematic review. JAMA (2008) 2.22
Associations between hemodialysis access type and clinical outcomes: a systematic review. J Am Soc Nephrol (2013) 2.22
Population based screening for chronic kidney disease: cost effectiveness study. BMJ (2010) 2.19
CKD and risk of hospitalization and death with pneumonia. Am J Kidney Dis (2009) 2.17
Proteinuria and life expectancy. Am J Kidney Dis (2012) 2.16
Cost of acute renal failure requiring dialysis in the intensive care unit: clinical and resource implications of renal recovery. Crit Care Med (2003) 2.13
Rate of kidney function decline in older adults: a comparison using creatinine and cystatin C. Am J Nephrol (2009) 2.10
Impact of anemia on hospitalization and mortality in older adults. Blood (2006) 2.07
Systematic review and meta-analysis: when one study is just not enough. Clin J Am Soc Nephrol (2008) 2.06
Infection risk with bolus versus maintenance iron supplementation in hemodialysis patients. J Am Soc Nephrol (2013) 2.06
Meta-analysis: antibiotics for prophylaxis against hemodialysis catheter-related infections. Ann Intern Med (2008) 2.06
Short-term change in kidney function and risk of end-stage renal disease. Nephrol Dial Transplant (2012) 2.01
Trends in anemia management among US hemodialysis patients. J Am Soc Nephrol (2002) 1.92
Trends in the use and outcomes of implantable cardioverter-defibrillators in patients undergoing dialysis in the United States. Am J Kidney Dis (2011) 1.92
Access to health care among status Aboriginal people with chronic kidney disease. CMAJ (2008) 1.91
Chronic kidney disease and life expectancy. Nephrol Dial Transplant (2012) 1.90
Quality of care and mortality are worse in chronic kidney disease patients living in remote areas. Kidney Int (2010) 1.89
Associations among estimated glomerular filtration rate, proteinuria, and adverse cardiovascular outcomes. Clin J Am Soc Nephrol (2011) 1.89
Preoperative statin use and postoperative acute kidney injury. Am J Med (2012) 1.87
Associations between acute kidney injury and cardiovascular and renal outcomes after coronary angiography. Circulation (2011) 1.85
Effects of fibrates in kidney disease: a systematic review and meta-analysis. J Am Coll Cardiol (2012) 1.84
Educational level as a determinant of access to and outcomes after kidney transplantation in the United States. Am J Kidney Dis (2008) 1.84
Potential cost savings of erythropoietin administration in end-stage renal disease. Am J Med (2002) 1.83
Nephrologist care and mortality in patients with chronic renal insufficiency. Arch Intern Med (2002) 1.82
Age, race, diabetes, blood pressure, and mortality among hemodialysis patients. J Am Soc Nephrol (2010) 1.81
Epidemiology and sociodemographics of systemic lupus erythematosus and lupus nephritis among US adults with Medicaid coverage, 2000-2004. Arthritis Rheum (2013) 1.80
National profile of practice patterns for hemodialysis vascular access in the United States. J Am Soc Nephrol (2002) 1.79
A propensity analysis of late versus early nephrologist referral and mortality on dialysis. J Am Soc Nephrol (2003) 1.78
The impact of selecting a high hemoglobin target level on health-related quality of life for patients with chronic kidney disease: a systematic review and meta-analysis. Arch Intern Med (2009) 1.77
Recommendations for growth monitoring, and prevention and management of overweight and obesity in children and youth in primary care. CMAJ (2015) 1.77
Commentary on 'The DOPPS practice monitor for U.S. dialysis care: update on trends in anemia management 2 years into the bundle': iron(y) abounds 2 years later. Am J Kidney Dis (2013) 1.76
Clinical Practice Guidelines and Recommendations on Peritoneal Dialysis Adequacy 2011. Perit Dial Int (2011) 1.76
NSAID use and progression of chronic kidney disease. Am J Med (2007) 1.75
Hemodialysis clinical practice guidelines for the Canadian Society of Nephrology. J Am Soc Nephrol (2006) 1.74
Delayed nephrologist referral and inadequate vascular access in patients with advanced chronic kidney failure. J Clin Epidemiol (2002) 1.73
Economic evaluation of sevelamer in patients with end-stage renal disease. Nephrol Dial Transplant (2007) 1.73
Genetic variation in APOL1 associates with younger age at hemodialysis initiation. J Am Soc Nephrol (2011) 1.70
Variation in nephrologist visits to patients on hemodialysis across dialysis facilities and geographic locations. Clin J Am Soc Nephrol (2013) 1.69
Trends in the incidence, demographics, and outcomes of end-stage renal disease due to lupus nephritis in the US from 1995 to 2006. Arthritis Rheum (2011) 1.68
The hepatotoxicity of antifungal medications in bone marrow transplant recipients. Clin Infect Dis (2005) 1.67
Anemia management and association of race with mortality and hospitalization in a large not-for-profit dialysis organization. Am J Kidney Dis (2009) 1.66
Kidney stones and cardiovascular events: a cohort study. Clin J Am Soc Nephrol (2013) 1.65
Association between multidisciplinary care and survival for elderly patients with chronic kidney disease. J Am Soc Nephrol (2007) 1.60
Kidney stones and kidney function loss: a cohort study. BMJ (2012) 1.58
Trends in anemia care in older patients approaching end-stage renal disease in the United States (1995-2010). JAMA Intern Med (2014) 1.58
A cluster randomized trial of an enhanced eGFR prompt in chronic kidney disease. Clin J Am Soc Nephrol (2012) 1.57
Variation in initial kidney replacement therapy for end-stage renal disease due to lupus nephritis in the United States. Arthritis Care Res (Hoboken) (2011) 1.57
Erythropoiesis-stimulating agents for anaemia in adults with chronic kidney disease: a network meta-analysis. Cochrane Database Syst Rev (2014) 1.55